Copyright
©The Author(s) 2020.
World J Gastroenterol. Jun 21, 2020; 26(23): 3236-3248
Published online Jun 21, 2020. doi: 10.3748/wjg.v26.i23.3236
Published online Jun 21, 2020. doi: 10.3748/wjg.v26.i23.3236
Table 5 Podoplanin expression pre- and post-neoadjuvant chemoradiaton
| Endoscopic biopsies pre RTx/CTx | Post RTx/CTx resected tissue | ||||
| Podoplanin expression | Patients, n | 0-5% | 6%-35% | 36%-65% | > 65% |
| 0-5% | 35 | 34 | 1 | 0 | 0 |
| 6%-35% | 14 | 10 | 3 | 1 | 0 |
| 36%-65% | 3 | 3 | 0 | 0 | 0 |
| > 65% | 4 | 3 | 1 | 0 | 0 |
- Citation: Warnecke-Eberz U, Plum P, Schweinsberg V, Drebber U, Bruns CJ, Müller DT, Hölscher AH, Bollschweiler E. Neoadjuvant chemoradiation changes podoplanin expression in esophageal cancer patients. World J Gastroenterol 2020; 26(23): 3236-3248
- URL: https://www.wjgnet.com/1007-9327/full/v26/i23/3236.htm
- DOI: https://dx.doi.org/10.3748/wjg.v26.i23.3236